Paper191908
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
Ondetti MA and 2 others. Science, 1977. Cited by 1,544 papers, by iCite.
Cite this record
ConductScience Library. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Papers, record 191908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/191908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin-Converting Enzyme Inhibitors | Major topic |
| Antihypertensive Agents | Major topic |
| Proline | Major topic |
| Administration, Oral | |
| Amino Acids, Sulfur | |
| Animals | |
| Binding Sites | |
| Biological Assay | |
| Blood Pressure | |
| Hypertension, Renal | |
| Ligands | |
| Male | |
| Rats | |
| Structure-Activity Relationship | |
| Succinates | |
| Teprotide | |
| Zinc |
Source PubMed
Cited by247
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,544 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930462 | Marine Fish-Derived ACE-Inhibitory Peptides: Preparation via Enzymatic Hydrolysis and Their In Vitro Activity. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42930462 | PubMed |
| 42206605 | Dissecting conserved molecular mechanisms of biological toxin activity through CRISPR screening. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42206605 | PubMed |
| 41214372 | Therapeutic potential of Bothrops leucurus phospholipase A2 in preventing dengue virus infection. | Arch Virol | 2025 | https://conductscience.org/library/papers/41214372 | PubMed |
| 41155192 | Therapeutic Promise and Biotechnological Prospects of Dendroaspis polylepis Venom Proteins: Mambalgins, Fasciculins, and Dendrotoxins. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155192 | PubMed |
| 41011245 | Small Molecule Protease Inhibitors as Model Peptidomimetics. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011245 | PubMed |
| 40868867 | Research Progress on the Mechanism of Action of Food-Derived ACE-Inhibitory Peptides. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40868867 | PubMed |
| 40864047 | Animal Venom in Modern Medicine: A Review of Therapeutic Applications. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864047 | PubMed |
| 40824896 | Molecular basis of domain-specific angiotensin I-converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat. | FEBS J | 2026 | https://conductscience.org/library/papers/40824896 | PubMed |
| 39926504 | Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide. | ACS Omega | 2025 | https://conductscience.org/library/papers/39926504 | PubMed |
| 39918873 | Molecular dissection of the role of ACE2 in glucose homeostasis. | Physiol Rev | 2025 | https://conductscience.org/library/papers/39918873 | PubMed |
| 39822771 | Control of metalloenzyme activity using photopharmacophores. | Coord Chem Rev | 2024 | https://conductscience.org/library/papers/39822771 | PubMed |
| 39411528 | Design, Synthesis, and Structural Evaluation of Acetylated Phenylthioketone Inhibitors of HDAC10. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/39411528 | PubMed |
| 39330868 | Identification of New Angiotensin-Converting Enzyme Inhibitory Peptides Isolated from the Hydrolysate of the Venom of Nemopilema nomurai Jellyfish. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39330868 | PubMed |
| 39046229 | Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. | Biosci Rep | 2024 | https://conductscience.org/library/papers/39046229 | PubMed |
| 38298628 | ACE inhibitors and their interaction with systems and molecules involved in metabolism. | Heliyon | 2024 | https://conductscience.org/library/papers/38298628 | PubMed |
| 38284547 | The ACE inhibitor captopril inhibits ACN-1 to control dauer formation and aging. | Development | 2024 | https://conductscience.org/library/papers/38284547 | PubMed |
| 38276526 | A Review of Rattlesnake Venoms. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/38276526 | PubMed |
| 38067446 | Quantitative Structure-Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity. | Molecules | 2023 | https://conductscience.org/library/papers/38067446 | PubMed |
| 37807412 | Automation of Drug Discovery through Cutting-edge In-silico Research in Pharmaceuticals: Challenges and Future Scope. | Curr Comput Aided Drug Des | 2024 | https://conductscience.org/library/papers/37807412 | PubMed |
| 37755948 | Sérgio Ferreira and Bothrops jararaca at the Royal College of Surgeons, London. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/37755948 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/191908
GET https://conductscience.org/api/papers/v1/191908/cited_by?page=2